INTRODUCTION
The medical aesthetics industry is a high-growth industry slated to reach 18 billion by 2027. This growth is primarily driven by minimally invasive and non-invasive cosmetic procedures according to All the Research 2020 Report.1
This study was conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. Chemical peels and neurotoxins have been used cosmetically to improve patient concerns as monotherapies. This study aimed to confirm that the same-day treatment combination creates no additional side effects and that patient results and satisfaction are heightened as a result.
Trials on chemical peels and botulinum toxin are vast, but research on the combination of the two therapies is minimal. One study published in 2006 by Marina Landau, MD, addressed the combination with the inclusion of both staggered and same day treatments.3 The findings indicated safety of same-day applications if only superficial and medium-depth chemical peels were used in treatment.
The top 5 most performed minimally invasive therapies reported by the American Society of Plastic Surgeons include Botulinum Toxin Type A, Soft Tissue Fillers, Chemical Peels, Laser Skin Resurfacing, and Intense Pulsed Light treatments comprising over 13 million patient visits in 2020.2 The diversity in the market continues to also evolve with not only a greater percentage of men receiving cosmetic treatments but also growth in familial aesthetics with grandparents, parents, and their adult children seeking both preventative and corrective care. As the aesthetic market continues to grow, advancements in optimal care have also evolved.
This study was conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. Chemical peels and neurotoxins have been used cosmetically to improve patient concerns as monotherapies. This study aimed to confirm that the same-day treatment combination creates no additional side effects and that patient results and satisfaction are heightened as a result.
Collagen degradation and wrinkling of the skin are caused by multiple intrinsic and extrinsic factors. Addressing wrinkling in the skin is often accomplished by reducing muscle contractions with the aid of neurotoxins as well as the use of chemical peels to improve skin elasticity, stimulate collagen regeneration, and textural refinements.
Trials on chemical peels and botulinum toxin are vast, but research on the combination of the two therapies is minimal. One study published in 2006 by Marina Landau, MD, addressed the combination with the inclusion of both staggered and same day treatments.3 The findings indicated safety of same-day applications if only superficial and medium-depth chemical peels were used in treatment.